UNC Lineberger

North Carolina's only public comprehensive cancer center, serving patients at the N.C. Basnight Cancer Hospital. Today's best care. Tomorrow's best hope.

[UNC Lineberger @UNC_Lineberger]

Last year, UNC Lineberger celebrated 50 years of standing at the forefront of cancer research, care, prevention and innovation, transforming lives across North Carolina and beyond. Today, we continue looking ahead to a future of even greater impact 🩵

[Urology@UNC @UNCurology]

Providing #ProstateCancer education & free testing in the community! @UNCurology, @UNC_Lineberger & @RAPCancer teamed up for a NC initiative at local health rallies. Special thanks to @ncatsuaggies, @tanray22, @zach_feuer, @JulieEFarmer, Will Moore. #HBCU

https://t.co/clDBIOhaOC

[UNC Hematology-Oncology Fellowship @UNCHemeOnc]

Congrats Dr Abdou!! @UNC_Lineberger

[UNC Health @UNC_Health_Care]

On July 22, 2016, history was made at UNC Health when Roy Dreyfuss became the first patient @UNC_Lineberger to receive CAR T-cell therapy in a clinical trial.

Video description: A patient is greeted by a care provider with blue balloons in a UNC Health treatment room.

[UNC Lineberger @UNC_Lineberger]

Amazing honor for Dr. Sharpless! Congratulations 👏

[Jay Bhattacharya, MD, PhD @NIHDirector_Jay]

🙏It was my pleasure to attend the portrait unveiling ceremony that the Foundation for the National Institutes of Health (FNIH) hosted for Norman "Ned" Sharpless, M.D., on the main NIH campus in Bethesda.

Dr. Sharpless served with distinction in a variety of federal science roles, most notably as director of NIH's National Cancer Institute (NCI) from 2017-2022. During his tenure, he championed investigator-initiated science, advanced childhood cancer research, and promoted big data approaches to oncology, including the Childhood Cancer Data Initiative.
Beyond that, Dr. Sharpless led top research on tumor suppressor genes, cellular senescence, aging, and cancer biology.

America's understanding of cancer research is far better for Dr. Sharpless's service. 🔬

[UNC Lineberger @UNC_Lineberger]

Join UNC Lineberger Cancer Network on July 22 at 12 p.m. for a live Research to Practice webinar featuring Mihir Patel, MD, and Siddharth Sheth, DO, MPH, as they discuss:

“Treatment of Oropharyngeal Cancer: TORS or Not to TORS… Clinical Trials Driving the Answer.”

This educational session will explore how clinical trials are shaping treatment decisions and advancing patient care.

✅ Live webinar
✅ Healthcare CE credits available
✅ Free registration through our learning portal

Register today: https://t.co/igG7IUPG6y

[Urology@UNC @UNCurology]

🕵️‍♀️🕵️‍♀️🕵️‍♂️ we spy local @UNCUroOnc @UNC_Lineberger hero @BrianC_Miller

🤩🤩
🚀🚀🚀🚀🚀🚀🚀🚀

[HemOnc Today @HemOncToday]

The survival benchmark for early-stage #HepatocellularCarcinoma is more than 5 years, and new data show external beam radiation produces similar results.

🗨️ “This is a treatment I can confidently say is a good option,” @AndrewMMoon @UNC_Lineberger https://t.co/G8HA8ISAZ8

[UNC Lineberger @UNC_Lineberger]

Through support from UNC Lineberger, grants and private gifts, the Get Real and Heel program offers personalized fitness training to cancer patients at all stages of care – completely free of charge.

"When I learned I had breast cancer, it's like my body had failed me," said Eli Levene, a Durham resident and breast cancer survivor. "I think the Get Real and Heel program has helped me connect to my body again in this way that's different, but so valuable." https://t.co/IbkVrDtzC5

[Daniel Peters @DPetersMD]

One of the many great talks at @_MDEducation AML-ALL focus group. @LeukDocJZ of @UNC_Lineberger showing continued, impressive results of Menin-I 💊in NPM1 and KMT2Ar AML and emphasis on frontline combos. Tip of the iceberg!🧊 #leusm

[UNC Lineberger @UNC_Lineberger]

Xiaodong Wang, PhD, and Pengda Liu, PhD, were awarded a $3.8 million NCI grant to develop a promising targeted treatment for Ewing sarcoma, a rare and aggressive pediatric cancer.

Congratulations, Drs. Wang and Liu 👏 https://t.co/N8T2WXN0f9

[UNC Lineberger @UNC_Lineberger]

The 49th Annual UNC Lineberger Scientific Symposium focused on emerging discoveries in RNA biology and their potential to advance cancer research and treatment. The event also featured a poster session and the inaugural Earp Lecture, a new endowed lectureship.

Read about all the exciting highlights from our signature event! https://t.co/oeZYXNRh7K

[UNC Lineberger @UNC_Lineberger]

UNC Lineberger's Caterina Gallippi, PhD, is a biomedical engineer advancing ultrasound innovations to help clinicians detect and monitor disease in real time without radiation. This supports faster, more accessible care for cancer and other conditions.

Read all about Dr. Gallippi and her career in the Q&A below. https://t.co/ikDpXACuto

[Gaorav Gupta @guptalabunc]

Excited to share our review of molecular regulation/dysregulation of the cGAS/STING pathway. Kudos to co-authors Min-Guk Cho, Rachel Lee, and Jayce Johnson for leading this effort! @UNC_Lineberger @UNC_BCBP

[Science Signaling @scisignal]

Although the protein CDH1 usually acts as a tumor suppressor, surprising findings suggest it also correlates with poorer outcomes in patients with ccRCC and may act as a marker of immune activity against this form of #KidneyCancer. @UNC_Lineberger https://t.co/Kc0Q7kppOr

[Michael Galgano MD @MGalganoMD]

We are proud at @UNCneurosurgery to have our work featured on the front cover of this edition of Neurosurgical Focus Video on Navigation in Spinal Surgery.

The cover illustration not only captures the “all hands on deck” multidisciplinary approach to performing an en bloc sacrectomy, but also highlights the important role that navigation plays in creating precise osteotomy cuts prior to tumor delivery.

Within our video contribution to the journal, we describe several additional expanded indications of spinal navigation beyond pedicle screw placement:

1) Fully-navigated corpectomy
2) Spatial awareness during VCR to better understand the rostral / caudal / ventral limits of bony resection
3) Utilization of intra-op ultrasound in real-time to perform ventral impaction of retropulsed fragments after traumatic burst fractures

Thank you to one of our superb @UNC_SOM students and aspiring neurosurgeon, Daniel Faraj , for his continued dedication to helping me build an impactful repository of spine surgery video projects.

Link to this month’s edition of Neurosurgical Focus Video where you can find several other valuable contributions from other authors ⬇️⬇️⬇️

https://t.co/Y89u3k91ft

@UNC_Lineberger @UNCMedCenter @UNC_Health_Care @SGUAlumni @StGeorgesU

@AANSNeuro
@spinesection
@TheJNS
@Neuro_bkmed

#neurosurgery
#orthopedics

[UNC Lineberger @UNC_Lineberger]

UNC Lineberger's Justin Milner, PhD, highlights the breadth of his research program and the growing momentum behind his lab’s work in this Q&A.

"Early in my training, I became interested in what determines whether T cells remain functional or lose effectiveness over time. That question felt both fundamental and highly relevant to improving patient outcomes, and it has carried forward into everything my lab does today." https://t.co/NnJCU6ebk5

[UNC Lineberger @UNC_Lineberger]

Did you know that glioblastomas are the most common malignant brain tumor? Learn more about glioblastoma risk factors, symptoms, treatments and clinical trials. https://t.co/N049BF8auM

[Science Signaling @scisignal]

Although the protein CDH1 usually acts as a tumor suppressor, surprising findings suggest it also correlates with poorer outcomes in patients with ccRCC and may act as a marker of immune activity against this form of #KidneyCancer. @UNC_Lineberger https://t.co/Kc0Q7kppOr

[UNC Lineberger @UNC_Lineberger]

More big funding news! Andrew Moon, MD, MPH, and Louise Henderson, PhD, were awarded $400,000 for their new study on the early detection of liver cancer in patients with advanced types of liver disease.

Congrats, Drs. Moon and Henderson! 🎉 https://t.co/imxZNnnBnV